Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Helgo Magnussen, Beatrix Fyrnys & Roland Greguletz. (2019) Genuair®/Pressair® Inhaler in COPD: The Patient Perspective. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 196-205.
Read now
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Read now
Bo Ding, Mark Small, Gina Scheffel & Ulf Holmgren. (2018) Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine care. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 927-936.
Read now
Read now
Kwun Nok Mimi Man, Zhipeng Tian, David Chi-Leung Lam, Jennifer Man Fan Wan & Kian Cheng Tan-Un. (2018) Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1949-1963.
Read now
Read now
Ching Kuo Tan, Gui Quan Say & James B Geake. (2016) Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations. Therapeutics and Clinical Risk Management 12, pages 1433-1444.
Read now
Read now
Francesco Blasi, Giorgio Walter Canonica, Stefano Centanni, Carlo Mereu, Roberto Bernabei, Giuseppe Paolisso, Raffaele Antonelli Incalzi, Angelo Corsico, Fabiano Di Marco, Manlio Milanese, Francesco Pagano, Pierachille Santus, Nicola Scichilone, Massimo Sumberesi, Fulvio Braido & Ilaria Baiardini. (2016) Genuair® Usability Test: Results of a National Public Survey of the Elderly. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:3, pages 367-371.
Read now
Read now
Kirsten Koehorst-ter Huurne, Kris Movig, Paul van der Valk, Job van der Palen & Marjolein Brusse-Keizer. (2016) The influence of type of inhalation device on adherence of COPD patients to inhaled medication. Expert Opinion on Drug Delivery 13:4, pages 469-475.
Read now
Read now
Jose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, Maria Isabel Asensio-Cruz, Eduardo Márquez-Martín & Francisco Ortega-Ruiz. (2015) Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Preference and Adherence 9, pages 95-104.
Read now
Read now
Tony D’Urzo, James F Donohue, David Price, Marc Miravitlles & Edward Kerwin. (2015) Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:5, pages 519-532.
Read now
Read now
Andrea S Melani. (2015) Long-acting muscarinic antagonists. Expert Review of Clinical Pharmacology 8:4, pages 479-501.
Read now
Read now
Basil G Bereza, Anders Troelsgaard Nielsen, Sverrir Valgardsson, Michiel EH Hemels & Thomas R Einarson. (2015) Patient preferences in severe COPD and asthma: a comprehensive literature review. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 739-744.
Read now
Read now
Paul W Jones. (2015) Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 677-687.
Read now
Read now
Debra J Reid & Alexa A Carlson. (2014) Clinical use of aclidinium in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 369-379.
Read now
Read now
Federico Lavorini & Giovanni A Fontana. (2014) Inhaler technique and patient's preference for dry powder inhaler devices. Expert Opinion on Drug Delivery 11:1, pages 1-3.
Read now
Read now
Articles from other publishers (37)
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, Keshav Raj Paudel, Parteek Prasher, Vyoma K Patel, Leander Corrie, Dinesh Kumar Chellappan, Gaurav Gupta, Sachin Kumar Singh, Vandana Patravale, John Disouza & Kamal Dua. (2023) Inhalation drug delivery in combating pulmonary infections: Advances and challenges. Journal of Drug Delivery Science and Technology 89, pages 105022.
Crossref
Crossref
Manali Harshal Barve, Priti Kiran ShardulSatish Sundarrao Munne, Atul R BendaleVaishali Naphade, Vasim T. Pathan & Laxmikant B. Borse. (2023) Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology. Biosciences Biotechnology Research Asia 20:2, pages 433-447.
Crossref
Crossref
Raj Kumar, Piyush Mehta, Konathala Ravi Shankar, Manju A. K. Rajora, Yogendra Kumar Mishra, Ebrahim Mostafavi & Ajeet Kaushik. (2022) Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications. Pharmaceutical Research 39:11, pages 2831-2855.
Crossref
Crossref
Johanna Sulku, Christer Janson, Håkan Melhus, Björn Ställberg, Kristina Bröms, Marieann Högman, Karin Lisspers, Andrei Malinovschi & Elisabet I. Nielsen. (2022) Changes in critical inhaler technique errors in inhaled COPD treatment – A one-year follow-up study in Sweden. Respiratory Medicine 197, pages 106849.
Crossref
Crossref
Roberto Walter Dal Negro & Massimiliano Povero. (2021) A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy. Children 9:1, pages 28.
Crossref
Crossref
Débora Rafaelli de Carvalho, Larissa Araújo de Castro, Myriam Fernanda Merli, Josiane Marques Felcar, Lais Silva Vidotto, Dirce Shizuko Fujisawa & Vanessa Suziane Probst. (2021) Quali-quantitative analysis of adherence and perceived satisfaction of individuals with COPD after high-intensity training on land and in water: additional analysis from a randomized clinical trial. Fisioterapia e Pesquisa 28:2, pages 126-135.
Crossref
Crossref
Mario Malerba, Beatrice Ragnoli, Danila Azzolina, Paolo Montuschi & Alessandro Radaeli. (2021) Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma. Frontiers in Pharmacology 12.
Crossref
Crossref
Michael Dreher, David Price, Asparuh Gardev, Pascale Peeters, Satish Arora, Simone van der Sar – van der Brugge, Richard Dekhuijzen & Omar S Usmani. (2021)
Patient perceptions of the re-usable Respimat
®
Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
. Chronic Respiratory Disease 18, pages 147997312098622.
Crossref
Crossref
Christian Taube, Valentina Bayer, Christoph Michael Zehendner & Arschang Valipour. (2020) Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice. Pulmonary Therapy 6:2, pages 371-380.
Crossref
Crossref
Massimiliano Povero, Paola Turco, Luca Bonadiman & Roberto W. Dal Negro. (2020) The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability. Multidisciplinary Respiratory Medicine 15.
Crossref
Crossref
Kazunori Kadota, Nana Inoue, Yoshihiro Matsunaga, Tetsushi Takemiya, Kenji Kubo, Hideki Imano, Hiromasa Uchiyama & Yuichi Tozuka. (2019) Numerical simulations of particle behaviour in a realistic human airway model with varying inhalation patterns. Journal of Pharmacy and Pharmacology 72:1, pages 17-28.
Crossref
Crossref
Roberto W. Dal Negro, Paola Turco & Massimiliano Povero. (2019) Patients’ usability of seven most used dry-powder inhalers in COPD. Multidisciplinary Respiratory Medicine 14:1.
Crossref
Crossref
Mario Malerba, Valentina Foci, Filippo Patrucco, Patrizia Pochetti, Matteo Nardin, Corrado Pelaia & Alessandro Radaeli. (2019) Single Inhaler LABA/LAMA for COPD. Frontiers in Pharmacology 10.
Crossref
Crossref
S N Avdeev & N V Trushenko. (2019) New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:3, pages 76-85.
Crossref
Crossref
Anthony D. D’Urzo, Dave Singh, James F. Donohue & Kenneth R. Chapman. (2019) Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base. Therapeutic Advances in Respiratory Disease 13, pages 175346661985072.
Crossref
Crossref
Han Ni, Soe Moe, Zay Soe, Kay Thi Myint & K Neelakantan Viswanathan. (2018) Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Omar Sharif Usmani, Federico Lavorini, Jonathan Marshall, William Christopher Nigel Dunlop, Louise Heron, Emily Farrington & Richard Dekhuijzen. (2018) Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respiratory Research 19:1.
Crossref
Crossref
Janwillem W. H. Kocks, Henry Chrystyn, Job van der Palen, Mike Thomas, Louisa Yates, Sarah H. Landis, Maurice T. Driessen, Mugdha Gokhale, Raj Sharma & Mathieu Molimard. (2018) Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. npj Primary Care Respiratory Medicine 28:1.
Crossref
Crossref
Roberto W. Dal Negro, Pietro Longo, Orestepaolo Villanis Ziani, Luca Bonadiman & Paola Turco. (2017) Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study. Multidisciplinary Respiratory Medicine 12:1.
Crossref
Crossref
Natalia Hawken, Saku Torvinen, Mohamed-Elmoctar Neine, Ikbel Amri, Mondher Toumi, Samuel Aballéa, Adam Plich & Nicolas Roche. (2017) Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
Nathalie Wauthoz, Ismaël Hennia, Bieke Dejaeger, Susana Ecenarro & Karim Amighi. (2017) Proposed algorithm for healthcare professionals based on product characteristics and in vitro performances in different use conditions using formoterol-based marketed products for inhalation. International Journal of Pharmaceutics 530:1-2, pages 415-429.
Crossref
Crossref
James Mahon, Anita Fitzgerald, Julie Glanville, Richard Dekhuijzen, Josefine Glatte, Sascha Glanemann & Saku Torvinen. (2017) Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research. Respiratory Medicine 129, pages 98-116.
Crossref
Crossref
Hiroyuki Ohbayashi, Sahori Kudo & Masatake Ishikawa. (2017) Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study. Pulmonary Therapy 3:1, pages 173-185.
Crossref
Crossref
Jo Riley & Phillip Krüger. (2017) Optimising inhaler technique in chronic obstructive pulmonary disease: a complex issue. British Journal of Nursing 26:7, pages 391-397.
Crossref
Crossref
Kevin Marsh, Erica Zaiser, Panagiotis Orfanos, Suzanne Salverda, Teresa Wilcox, Shawn Sun & Shailja Dixit. (2017) Evaluation of COPD Treatments: A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States. Value in Health 20:1, pages 132-140.
Crossref
Crossref
Roberto W. Dal Negro & Massimiliano Povero. (2016) Dry-powder inhalers in patients with persistent airflow limitation: usability and preference. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Roberto W. Dal Negro & Massimiliano Povero. (2016) Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Vicente Plaza Moral & Jordi Giner Donaire. (2016) Terapia inhalada en el asma. Medicina Clínica 146:7, pages 316-323.
Crossref
Crossref
Vicente Plaza Moral & Jordi Giner Donaire. (2016) Inhaled therapy in asthma. Medicina Clínica (English Edition) 146:7, pages 316-323.
Crossref
Crossref
Mario Cazzola & Paola Rogliani. 2015. Controversies in COPD. Controversies in COPD
213
223
.
P. Devillier, H. Salvator & N. Roche. (2015) Le choix du dispositif d’inhalation (hors nébulisation) : un acte médical. Revue des Maladies Respiratoires 32:6, pages 599-607.
Crossref
Crossref
Katharina Marth, Elisabeth Schuller & Wolfgang Pohl. (2015) Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD. Respiratory Medicine 109:5, pages 616-624.
Crossref
Crossref
Sergi Pascual, Jan Feimer, Anthony De Soyza, Jaume Sauleda Roig, John Haughney, Laura Padullés, Beatriz Seoane, Ludmyla Rekeda, Anna Ribera & Henry Chrystyn. (2015) Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study. npj Primary Care Respiratory Medicine 25:1.
Crossref
Crossref
K. Suresh Babu & Jaymin B. Morjaria. (2015) Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:2, pages 56-68.
Crossref
Crossref
Han Ni, Zay Soe & Soe Moe. (2014) Aclidinium bromide for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015:4.
Crossref
Crossref
M. Hoppentocht, P. Hagedoorn, H.W. Frijlink & A.H. de Boer. (2014) Technological and practical challenges of dry powder inhalers and formulations. Advanced Drug Delivery Reviews 75, pages 18-31.
Crossref
Crossref
Job van der Palen. (2014)
Genuair
®
in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry-powder inhaler
. Therapeutic Delivery 5:7, pages 795-806.
Crossref
Crossref